CD95's deadly mission in the immune system

Nature

Volumn 407, Issue 6805, 2000, Pages 789-795

  Krammer, P H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; ENZYME PRECURSOR; FAS ANTIGEN; FAS LIGAND; PROCASPASE 8; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN PRESENTING CELL; APOPTOSIS; B LYMPHOCYTE; CELL DEATH; CELL GROWTH; CELL MATURATION; CELL SURVIVAL; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; LYMPHATIC SYSTEM TUMOR; LYMPHOCYTE; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMUS;

ANIMAL; ANTIGENS, CD95; APOPTOSIS; B-LYMPHOCYTES; CARRIER PROTEINS; HUMAN; MEMBRANE GLYCOPROTEINS; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0034641898     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35037728     Document Type: Review

References (98)

1. Somatic generation of antibody diversity
2. Signal transduction pathways that regulate the fate of B lymphocytes
3. Selection of the T cell repertoire
4. How can dendritic cells cause autoimmune disease?
5. Peripheral T-cell self-reactivity and immunological memory
6. A central role for thymic emigrants in peripheral T cell homeostasis
7. CD95(APO-1/Fas)-mediated apoptosis: Live and let die
8. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI
9. Three functional soluble form s of the human apoptosis-inducing Fas molecule are produced by alternative splicing
10. Activation interferes with the APO-1 pathway in mature human T cells
11. Constitutive and induced expression of Apo-I, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells
12. Controlling cell death
13. Cleavage of FLICE (caspase-8) by granzyme B during cytotoxic T lymphocyte-induced apoptosis
14. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles
15. The regulation of CD95 ligand expression and function in CTL
16. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases
17. Fas ligand in human serum
18. Fas-mediated cytotoxicity - A new immunoregulatory and pathogenic function of Thl CD4+ T cells
19. Expression of the functional soluble form of human fas ligand in activated lymphocytes
20. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing
21. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor
22. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
23. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations
24. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling
25. Two CD95 (APO-1/Fas) signaling pathways
26. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
27. Cleavage of BID by caspese 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
28. The pharmacology of T cell apoptosis
29. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
30. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins
31. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
32. Viral Flice-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
33. A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis
34. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1 -induced apoptosis
35. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development
36. TRAIL receptor-2 signals apoptosis through FADD and caspase-8
37. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
38. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5
39. The size of functional T-lymphocyte pools within thymic medullary and cortical cell subsets
40. T-cell apoptosis detected in situ during positive and negative selection in the thymus
41. Thymocyte selection: Not by TCR alone
42. The thymus and central tolerance
43. FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor
44. When apoptosis fails
45. A role for Fas in negative selection of thymocytes in vivo
46. Thymic dendritic cells express inducible nitric oxide synthase and generate nitric oxide in response to self- and alloantigens
47. Biology of the interleukin-2 receptor
48. Autocrine 1-cell suicide mediated by APO-1/(Fas/CD95)
49. Fas ligand mediates activation-induced cell death in human T lymphocytes
50. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates : Ctivation-induced apoptosis in T-cell hybridomas
51. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
52. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance
53. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice
54. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells
55. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death
56. Induction of apoptosis in mature T cells by tumour necrosis factor
57. + memory T cells in virus-infected hosts
58. Reactive oxygen species regulate activation-induced T cell apoptosis
59. A role for perforin in activation-induced T cell death in vivo: Increased expansion of allogeneic perforin-deficient T cells in SCID mice
60. + T cells
61. Upregulation of c-FLIP and reduction of AICD in CD28 costimulated human T cells
62. TCR-mediated upregulation of c-FLIP, correlates with resistance towards CD95 mediated apoptosis by blocking DISC activity
63. Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes
64. CD28 and apoptosis
65. Rapid elimination of mature autoreactive B cells demonstrated by Cre-induced change in B cell antigen receptor specificity in vivo
66. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death
67. Critical role for mitocbondria in B cell receptor-mediated apoptosis
68. Mitochondria connects the antigen receptor to effector caspases during B cell receptor-induced apoptosis in normal human B cells
69. Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from APO-1/Fas-mediated apoptosis
70. bcl-2 Transgene expression inhibits apoptosis in the germinal center and reveals differences in the selection of memory B cells and bone marrow antibody-forming cells
71. Reversal of Blimp-1-mediated apoptosis by Al, a member of the Bcl-2 family
72. + tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts
73. Tolerant B lymphocytes acquire resistance to Fas-mediated apoptosis after treatment with interleukin 4 but not after treatment with specific antigen unless a surface immunoglobulin threshold is exceeded
74. TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation
75. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
76. B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1
77. The induction of tolerance by dendritic cells that have captured apoptotic cells
78. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
79. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
80. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway
81. CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells
82. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: A lesson from the mouse model
83. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
84. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity
85. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II
86. Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases
87. Bcl-2 family: Regulators of cell death
88. Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector
89. Activation of apoptosis pathways by anticancer drugs
90. Tumor counterattack-concept and reality
91. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120
92. The role of APO-1-mediated apoptosis in the immune system
93. High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children
94. Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children
95. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein
96. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes
97. Programmed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS. Molecular control and effect of highly active anti-retroviral therapy